Pharma news
Pharma
American pharmaceutical company Pfizer warned investors of little revenue growth to come in 2019, owing partly to expiring exclusivity rights on drugs including Viagra and the seizure medicine Lyrica. 31 January 2019
Americas
Global biopharmaceutical company Celgene has signed a collaboration deal worth up to nearly $1 billion to develop a preclinical therapeutic for the treatment of blood cancers, including leukaemia. 31 January 2019
Asia
Thailand’s government has suspended all patents for medical marijuana products, a little more than a month after the country’s parliament voted to approve marijuana for medical use and research. 29 January 2019
Asia
Indian pharmaceutical companies should be encouraged to grant compulsory licences and prices of some patented medicines should be capped, an Indian government panel has said. 28 January 2019
Americas
The US Court of Appeals for the Federal Circuit has overturned a reduction in the patent term adjustment owned by Supernus Pharmaceuticals. 24 January 2019
Pharma
The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver. 24 January 2019
Asia-Pacific
South Korean pharmaceutical companies entered into 11 out-licensing deals with overseas partners in 2018, according to the country’s Ministry of Health and Welfare. 22 January 2019
Pharma
Law firm HGF has added Leythem Wall as a partner. 22 January 2019
Americas
The US Patent and Trademark Office has declined to hear two petitions filed by Switzerland-based Novartis to review two patents owned by drug discovery company Plexxikon. 21 January 2019
Pharma
Novartis and the University of Oxford’s Big Data Institute have joined forces to use artificial intelligence for improving drug development, initially in the areas of multiple sclerosis, dermatology and rheumatology. 21 January 2019